Skip to main content
Premium Trial:

Request an Annual Quote

Wellcome Trust Sanger Institute Lands $2M for Whole Genome Disease Study

NEW YORK (GenomeWeb News) – Researchers at the Wellcome Trust Sanger Institute have won a €1.5 million ($2 million) Starting Grant from the European Research Council to search for genetic variants that are involved in human diseases.

A team led by principal investigator Eleftheria Zeggini will use the funding to focus their research on large-scale studies of the genetics of complex traits involved in cardiometabolic and musculoskeletal phenotypes with the goal of addressing specific statistical genetics challenges by designing, evaluating, and proposing new analytical strategies, Wellcome Trust said today.

The researchers will conduct a next-generation whole genome association study in cases where rare alleles may be easier to detect in order to provide the substrate for analytical method development, and to identify new associations with traits related to complex diseases.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.